After warning just last week of elevated risk at Teladoc Health (TDOC), the stock is down nearly 15% following the announced merger with Livongo Health (LVGO). The company has agreed to pay a massive $18.5 billion for the leading platform to monitor chronic conditions using their inflated currency. My negative investment thesis is further reinforced by the outrageous valuation of this acquisition.
Source: Teladoc Health website
Pricey Deal
The company agreed to pay $18.5 billion for Livongo Health on the day the company reported quarterly revenues of only $91.9 million to